ASCO26: Data highlights test benefit in breast cancer treatment planning and earlier detection - Medical Device Network

ASCO26: Data highlights test benefit in breast cancer treatment planning and earlier detection  Medical Device NetworkVeracyte genomic test identifies breast cancer patients who can skip chemo  The HinduMillions of breast cancer patients could safely avoid chemotherapy, study suggests  BBCGroundbreaking genomic test could spare millions of breast cancer patients chemotherapy  The GuardianPatients with High-Risk Breast Cancer May Safely Skip Chemo, Trial Finds  Cure Today